| Authors: |
Darbandi S; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Urbanucci A; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Center for Cancer Eradication Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Finland Tampere University, Tampere, Finland.; Finnish Cancer Institute., Hakkola S; Center for Cancer Eradication Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Finland Tampere University, Tampere, Finland., Gujral J; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Darbandi M; Department of Oncological Sciences, Tisch Cancer Institute, New York, USA., Eraky A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Nair S; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Chakraborty G; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Tewari A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA., Kyprianou N; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, New York, USA.; Department of Pathology & Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
